In this issue:
Drug survival may be improved by combined anti-TNF/csDMARD therapy
Efficacy of IXE is independent of concurrent MTX
PsA significantly impacts on sleep, pain and fatigue
Is the presence of enthesitis prognostic for increased disease severity?
Patient/physician misalignment regarding satisfaction with disease control
Obesity associated with increased disease activity
Obesity reduces the efficacy of tofacitinib
Pattern of drug use in patients with PsA in Italy
Latent tuberculosis infection is an uncommon adverse event of secukinumab treatment
Inflammatory hallmarks of lesser prominence in patients starting biologics
Please login below to download this issue (PDF)